Summit Securities Group LLC Buys Shares of 53,400 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Summit Securities Group LLC purchased a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 53,400 shares of the pharmacy operator’s stock, valued at approximately $498,000.

A number of other hedge funds have also made changes to their positions in WBA. State Street Corp lifted its stake in shares of Walgreens Boots Alliance by 18.0% in the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after buying an additional 6,569,223 shares during the last quarter. Norges Bank acquired a new position in Walgreens Boots Alliance during the 4th quarter worth $58,241,000. Two Sigma Advisers LP bought a new stake in Walgreens Boots Alliance during the third quarter valued at about $24,226,000. Vanguard Group Inc. grew its position in shares of Walgreens Boots Alliance by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock valued at $805,506,000 after purchasing an additional 2,279,495 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock worth $122,737,000 after purchasing an additional 2,185,950 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 0.3 %

WBA opened at $11.19 on Friday. The firm has a market cap of $9.67 billion, a price-to-earnings ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm’s 50-day simple moving average is $10.83 and its 200-day simple moving average is $9.91. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $21.74.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.66 EPS. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on WBA shares. Bank of America upped their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Truist Financial decreased their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Royal Bank of Canada lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Finally, Evercore ISI upped their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $10.59.

View Our Latest Analysis on WBA

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.